Skip to content
PatientMatchFind trials

Screener

Eligibility screening

Pembrolizumab + sEphB4 in Metastatic Urothelial Carcinoma

Sponsored by Vasgene Therapeutics, IncStudy detailsClinicalTrials.gov

1 US site in CA

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.